Skip to main content

Table 2 Characteristics of the HIV population of the “Hôpital neuchâtelois-Pourtalès” between November 2014 and December 2016 (based on the patients’ medical records for included patients and the data of the Swiss HIV Cohort Study, SHCS, for patients who refused or were not proposed participation)

From: Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results

 

Inclusion

Refusal

Not proposed

Number of patients

17

13

25

Gender (n, %)

 Male

10 (58.8%)

5 (38.5%)

15 (60.0%)

 Female

6 (35.3%)

5 (38.5%)

10 (40.0%)

 Transsexual

1 (5.9%)

0

0

 Missing data

0

3 (23.1%)

0

Age (year) (median, IQR)

36 (31–42)

52 (39–56)

49 (41–54)

Ethnicity

 White

12 (70.6%)

9 (69.2%)

16 (64.0%)

 Black

3 (17.6%)

1 (7.7%)

5 (20.0%)

 Other ethnicity

2 (11.8%)

0

4 (16.0%)

 Missing data

0

3 (23.1%)

0

Highest attained educational degree (n, %)

 Basica

1 (5.9%)

1 (7.7%)

5 (20.0%)

 Medium/highb

12 (70.6%)

9 (69.2%)

20 (80.0%)

 Unknown/Missing data

4 (23.5%)

3 (23.1%)

0

Most likely source of HIV infection

 Sexual contact

13 (76.4%)

8 (61.5%)

22 (88.0%)

 I.V. drug use/sexual contact (unclear which one)

2 (11.8%)

1 (7.7%)

3 (12.0%)

 Other sources

2 (11.8%)

1 (7.7%)

0

 Missing data

0

3 (23.1%)

0

ART description at inclusionc

 NRTI + NNRTI

7 (41.2%)

9 (69.2%)

15 (60.0%)

 NRTI + INSTI

6 (35.3%)

0

2 (8.0%)

 Other

3 (17.6%)

1 (7.7%)

5 (20.0%)

 No treatment

0

0

3 (12.0%)

 Missing data

1 (5.9%)

3 (23.1%)

0

Switch of treatment during the study (n, %)

7 (41.2%)

4 (30.8%)

6 (24.0%)

Treatment stop

0

1 (7.7%)

1 (4.0%)

Missing data

0

3 (23.1%)

0

ART line

 Naive patientsd

9 (53.0%)

0

0

 Experienced patients

8 (47.0%)

10 (76.9%)

24 (96.0%)

 Missing data

0

3 (23.1%)

1 (4.0%)

VL at inclusion

 Patients with < 50 copies/mL (n, %)

7 (41.2%)

10 (76.9%)

24 (96.0%)

 Patients with ≥50 copies/mL (n, %)

10 (58.8%)

0

1 (4.0%)

Missing data (n, %)

0

3 (23.1%)

0

CD4 at inclusion (median, IQR)

 CD4 count (cell/mm3)

583 (434–687)

753 (659.5–931.5)

648 (406.5–908.5)

Reasons for proposal (n, %)e

  

 Difficult psychosocial context

5

10

 

 Introduction of a new ART

8

1

 

 Difficulties described by the patient

2

1

 

 Suspected non-adherence by health professionals

3

0

 

 Other

1

1

 

Reasons for patient refusal (n, %)e

 

 Refused to change pharmacy

 

11

 

 Doesn’t feel the need for such support

 

2

 

 Fears about confidentiality

 

2

 
  1. Notes:
  2. a Did not complete school or professional education, mandatory school
  3. b Finished apprenticeship, bachelor’s degree, higher professional education, higher technical or commercial school, university or other equivalent educational degree
  4. c NRTI = nucleoside reverse-transcriptase inhibitors, NNRTI = non-nucleoside reverse-transcriptase inhibitors, INSTI = integrase inhibitors
  5. d First ART started < 1 month ago
  6. e More than one reason was possible